Residual normal stem cells can be detected in newly diagnosed chronic myeloid leukemia patients by a new flow cytometric approach and predict for optimal response to imatinib

J.J.W.M. Janssen, W. Deenik, K.G.M. Smolders, B.J. van Kuijk, W. Pouwels, A. Kelder, J.J. Cornelissen, G.J. Schuurhuis, G.J. Ossenkoppele

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)977-984
JournalLeukemia
Volume26
Issue number5
DOIs
Publication statusPublished - 2012

Cite this